Goldman Sachs
DRIO icon

Goldman Sachs’s DarioHealth DRIO Stock Holding History

Goldman Sachs’s Portfolio DRIO Stock Details DRIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-5,288
Closed -$126K – 5875
2024
Q2 		$126K Sell
5,288
-135
-2% -$3.83K ﹤0.01% 5373
2024
Q1 		$166K Buy
5,423
+157
+3% +$5.95K ﹤0.01% 5156
2023
Q4 		$181K Buy
5,266
+1,544
+41% +$55K ﹤0.01% 5182
2023
Q3 		$244K Buy
3,722
+1,869
+101% +$126K ﹤0.01% 4972
2023
Q2 		$149K Sell
1,853
-794
-30% -$60.3K ﹤0.01% 5269
2023
Q1 		$218K Buy
2,647
+24
+0.9% +$2.36K ﹤0.01% 5262
2022
Q4 		$224K Sell
2,623
-255
-9% -$23K ﹤0.01% 5254
2022
Q3 		$266K Sell
2,878
-548
-16% -$58.8K ﹤0.01% 5353
2022
Q2 		$420K Buy
3,426
+1,045
+44% +$123K ﹤0.01% 5204
2022
Q1 		$278K Sell
2,381
-307
-11% -$50.8K ﹤0.01% 5703
2021
Q4 		$698K Sell
2,688
-63
-2% -$19.2K ﹤0.01% 5125
2021
Q3 		$751K Buy
2,751
+551
+25% +$159K ﹤0.01% 4951
2021
Q2 		$940K Buy
2,200
+408
+23% +$155K ﹤0.01% 4815
2021
Q1 		$690K Buy
1,792
+220
+14% +$99.1K ﹤0.01% 4889
2020
Q4 		$449K Buy
1,572
+312
+25% +$80.4K ﹤0.01% 4670
2020
Q3 		$423K Sell
1,260
-106
-8% -$28.7K ﹤0.01% 4568
2020
Q2 		$173K Buy
1,366
+106
+8% +$14.1K ﹤0.01% 4845
2020
Q1 		$171K Hold
1,260
– – ﹤0.01% 4758
2019
Q4 		$165K Sell
1,260
-2
-0.2% -$221 ﹤0.01% 4942
2019
Q3 		$153K Sell
1,262
-7
-0.6% -$1.21K ﹤0.01% 4892
2019
Q2 		$236K Buy
1,269
+9
+0.7% +$2.33K ﹤0.01% 4717
2019
Q1 		$372K Buy
1,260
+1,204
+2,150% +$358K ﹤0.01% 4539
2018
Q4 		$17K Buy
+56
New +$20.1K ﹤0.01% 5158
2017
Q1 		– Sell
-35
Closed -$45K – 6807
2016
Q4 		$45K Sell
35
-9
-20% -$11.8K ﹤0.01% 6412
2016
Q3 		$63K Sell
44
-27
-38% -$42.4K ﹤0.01% 6398
2016
Q2 		$147K Buy
+71
New +$145K ﹤0.01% 5907

Other funds holding DRIO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
AWAM
Appian Way Asset Management New York $558M AUM 1.95% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
YDMI
Y.D. More Investments Ramat Gan, Israel $2.55B AUM 104.35% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Goldman Sachs's DRIO Position: Q3 2024 in Review

Goldman Sachs sold out of DarioHealth (DRIO) in Q3 2024, closing a stake of 5,288 shares — an estimated $126K sold.

Goldman Sachs first reported a position in DRIO in Q2 2016 and held it in 26 quarters. The position peaked at $940K in Q2 2021. 32 funds tracked by Wall St. Rank hold DRIO as of Q3 2024.

  • Goldman Sachs reported no remaining DarioHealth position as of Q3 2024 after selling out during the quarter.
  • Goldman Sachs sold 5,288 DarioHealth shares in Q3 2024, an estimated $126K.
  • Goldman Sachs first reported a position in DarioHealth in Q2 2016 and held it in 26 quarters.
  • Goldman Sachs's DarioHealth position peaked at $940K in Q2 2021.
  • 32 funds tracked by Wall St. Rank held DarioHealth as of Q3 2024.

Based on Goldman Sachs's 13F filing for Q3 2024, filed 14 Nov 2024.